Dergiler / Endoüroloji Bülteni / 2026 / Cilt: 18 Sayı: 3

Frailty Önemlidir: Modified Frailty Index-5 Skorunun Radikal Prostatektomide Postoperatif Sonuçları Öngörmede Başarısı

Frailty Matters: The Success of the Modified Frailty Index-5 Score in Predicting Postoperative Outcomes in Radical Prostatectomy

Osman Murat İpek(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL KARTAL DR. LÜTFİ KIRDAR HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, THE DEPARTMENT OF UROLOGY)0000-0002-1305-023X
Erdinç Dinçer(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL KARTAL DR. LÜTFİ KIRDAR HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, THE DEPARTMENT OF UROLOGY)0000-0002-0644-8282
Ahmet Halil Sevinc(Kartal Dr. Lütfi Kırdar Şehir Hastanesi)0000-0003-2965-1782
Burcu Hanci Sevinc(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL KARTAL DR. LÜTFİ KIRDAR HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, THE DEPARTMENT OF UROLOGY)0000-0001-6928-1654
Cengiz Çanakcı(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL KARTAL DR. LÜTFİ KIRDAR HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, THE DEPARTMENT OF UROLOGY)0000-0002-2654-1986
Yiğit Kudret Akyol(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL KARTAL DR. LÜTFİ KIRDAR HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, THE DEPARTMENT OF UROLOGY)0000-0002-3647-2603
Orkunt Özkaptan(UNIVERSITY OF HEALTH SCIENCES, İSTANBUL KARTAL DR. LÜTFİ KIRDAR HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, THE DEPARTMENT OF UROLOGY)0000-0003-3659-1319
Sayfa
141–149
Yayın Tarihi
2026-09-30
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Demografik özellikler, komorbidite profilleri, histopatolojik bulgular, perioperatif değişkenler, postoperatif komplikasyonlar ve takip sonuçları değerlendirilmiştir.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Amaç: Radikal prostatektomi uygulanan hastalar genellikle ileri yaş popülasyonuna aittir; bu nedenle kronolojik yaşa ek olarak, frailty (kırılganlık) klinik sonuçlar üzerinde önemli bir etkiye sahiptir.
📊
Temel Bulgular & Veri:Bu çalışmanın amacı, radikal prostatektomi uygulanan hastalarda modifiye frailty indeksinin (mFI-5) postoperatif komplikasyonlar ve fonksiyonel sonuçlarını öngörmedeki başarısını değerlendirmektir.
💡
Sonuç & Katkı:Demografik özellikler, komorbidite profilleri, histopatolojik bulgular, perioperatif değişkenler, postoperatif komplikasyonlar ve takip sonuçları değerlendirilmiştir.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 · 200 hasta
⚙️Değişkenler:prostat kanseri · radikal prostatektomi · modifiye kırılganlık indeks-5

Özet

Amaç: Radikal prostatektomi uygulanan hastalar genellikle ileri yaş popülasyonuna aittir; bu nedenle kronolojik yaşa ek olarak, frailty (kırılganlık) klinik sonuçlar üzerinde önemli bir etkiye sahiptir. Bu çalışmanın amacı, radikal prostatektomi uygulanan hastalarda modifiye frailty indeksinin (mFI-5) postoperatif komplikasyonlar ve fonksiyonel sonuçlarını öngörmedeki başarısını değerlendirmektir. Gereç ve Yöntemler: Ocak 2016 ile Ocak 2024 tarihleri arasında yüksek hacimli bir üçüncü basamak merkezde radikal prostatektomi uygulanan 200 hastanın verileri retrospektif olarak analiz edilmiştir. Demografik özellikler, komorbidite profilleri, histopatolojik bulgular, perioperatif değişkenler, postoperatif komplikasyonlar ve takip sonuçları değerlendirilmiştir. Hastalar, preoperatif mFI-5 skorlarına göre yüksek risk (≥ 2) ve düşük risk (< 2) olarak sınıflandırılmıştır. Postoperatif komplikasyonlar birincil sonlanım noktası olarak belirlenirken, fonksiyonel sonuçlar ikincil sonlanım noktaları olarak değerlendirilmiştir. Bulgular: Çalışmaya 200 erkek hasta dahil edilmiş olup, ortalama yaş 64,7 ± 6,03 yıl olarak bulunmuştur. 200 hastanın 54’ü (%27) yüksek risk grubunda (mFI-5 ≥ 2), 146’sı (%73) ise düşük risk grubunda (mFI-5 < 2) yer almıştır. Majör komplikasyon oranı (Clavien-Dindo ≥ 3) yüksek risk grubunda anlamlı derecede daha yüksek bulunurken, toplam komplikasyon oranı gruplar arasında benzer saptanmıştır. Tekrar başvuru ve re-operasyon oranları yüksek risk grubunda daha yüksek bulunmuş, ancak bu fark istatistiksel anlamlılığa ulaşmamıştır. Fonksiyonel sonuçlar açısından, erektil disfonksiyon ve üriner inkontinans oranlarının gruplar arasında benzer olduğu görülmüştür. Sonuçlar: Bu çalışma, radikal prostatektomi uygulanan hastalarda daha yüksek mFI-5 skorları ile daha yüksek majör komplikasyon oranları arasındaki ilişkiyi ortaya koymaktadır. Frailte değerlendirmesinde basit ve maliyet etkin bir ölçüt olan mFI-5, bu hasta grubunda preoperatif risk sınıflandırması ve hasta seçimi açısından önemli bir rol oynayabilir.

Abstract

Objective: Patients undergoing radical prostatectomy generally belong to an older population; therefore, in addition to chronological age, frailty has a substantial impact on clinical outcomes. This study aimed to evaluate the predictive value of the modified frailty index (mFI-5) for post-operative complications and functional outcomes in patients undergoing radical prostatectomy. Materials and Methods: A retrospective analysis was conducted on 200 individuals who underwent radical prostatectomy between January 2016 and January 2024 in a high-volume tertiary center. Data collection included demographic characteristics, comorbidity profiles, histopathological findings, perioperative variables, postoperative complications and follow-up outcomes. Patients were stratified as having either high risk (≥ 2) or low risk (< 2) according to pre-operative mFI-5 scores. Postoperative complications constituted the primary endpoint, whereas functional outcomes were assessed as secondary endpoints. Results: The study included 200 male patients, with a mean age of 64.7 ± 6.03 years. Fifty-four out of 200 patients (27%) were in the high-risk group (mFI-5 ≥ 2) while 146 patients (73%) were in low-risk group (mFI-5 < 2). While the rate of major complications (Clavien-Dindo ≥ 3) was significantly higher in high-risk group, the overall complication rate was similar between the groups. Readmission and reoperation rates were increased in the high-risk group; however, the difference did not reach statistical significance. Regarding functional outcomes, erectile dysfunction and urinary incontinence rates were similar between the groups. Conclusion: This study highlights an association between higher mFI-5 scores and an increased risk of major postoperative complications after radical prostatectomy. Although mFI-5 should not be used as a stand-alone criterion for treatment selection, it may serve as a simple, rapid, and cost-effective adjunctive tool for preoperative risk stratification and individualized surgical decision-making.

🔖

Bu Makaleye Atıf Yap

İpek, O. M., Dinçer, E., Sevinc, A. H., Sevinc, B. H., Çanakcı, C., Akyol, Y. K., Özkaptan, O. (2026). Frailty Önemlidir: Modified Frailty Index-5 Skorunun Radikal Prostatektomide Postoperatif Sonuçları Öngörmede Başarısı. Endoüroloji Bülteni, Cilt: 18 Sayı: 3, 141–149. https://doi.org/10.54233/endourolbull-1883616

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (21)

  1. Porcaro AB, Bianchi A, Gallina S, Serafin E, Mazzucato G et al. Advanced age portends poorer prognosis after radical prostatectomy: a single center experience. Aging Clin Exp Res. 2022;34:2857–63. https://doi.org/10.1007/s40520-022-02213-w
  2. Shahait M, Labban M, Dobbs RW, Cheaib JG, Lee DI et al. A 5-Item Frailty Index for Predicting Morbidity and Mortality After Radical Prostatectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database. J Endourol. 2021;35:483–9. https://doi.org/10.1089/end.2020.0597
  3. Zattoni F, Montebelli F, Rossanese M, Crestani A, Giannarini G et al. Should radical prostatectomy be encouraged at any age? A critical non-systematic review. Minerva Urol Nefrol. 2018;70:42–52. https://doi.org/10.23736/S0393-2249.17.02953-8
  4. Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. The Journal of urology. 2006;175:99–103. https://doi.org/10.1016/S0022-5347(05)00018-2
  5. Tewari A, Johnson CC, Divine G, Crawford ED, Gamito EJ et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol. 2004;171:1513–9. https://doi.org/10.1097/01.ju.0000117975.40782.95
  6. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol. 1996;156:127–32. https://doi.org/10.1016/S0022-5347(01)65964-0
  7. Walz J, Gallina A, Saad F, Montorsi F, Perrotte P et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol. 2007;20:3576–81. https://doi.org/10.1200/JCO.2006.10.3820
  8. Velanovich V, Antoine H, Swartz A, Peters D, Rubinfeld I. Accumulating deficits model of frailty and postoperative mortality and morbidity: its application to a national database. J Surg Res. 2013;183:104–10. https://doi.org/10.1016/j.jss.2013.01.021
  9. Tsiouris A, Hammoud ZT, Velanovich V, Hodari A, Borgi J et al. A modified frailty index to assess morbidity and mortality after lobectomy. J Surg Res. 2013;183:40–6. https://doi.org/10.1016/j.jss.2012.11.059
  10. Levy I, Finkelstein M, Bilal KH, Palese M. Modified frailty index associated with Clavien-Dindo IV complications in robot-assisted radical prostatectomies: A retrospective study. Urol Oncol. 2017;35:425–31. https://doi.org/10.1016/j.urolonc.2017.01.005
  11. Chimukangara M, Helm MC, Frelich MJ, Bosler ME, Rein LE et al. A 5-item frailty index based on NSQIP data correlates with outcomes following paraesophageal hernia repair. Surg Endosc. 2017;31:2509–19. https://doi.org/10.1007/s00464-016-5253-7
  12. Goldwag J, Harris A, Bettis AD. 5-ITEM modified frailty index as a preoperative predictor of morbidity following minimally invasive partial nephrectomy. Urology. 2021;157:138–42. https://doi.org/10.1016/j.urology.2021.05.050
  13. Marano L, Carbone L, Poto GE, Gambelli M, Noudem LLN et al. Handgrip strength predicts length of hospital stay in an abdominal surgical setting: the role of frailty beyond age. Aging Clin Exp Res. 2022;34:811–7. https://doi.org/10.1007/s40520-022-02121-z
  14. Rosiello G, Palumbo C, Knipper S, Deuker M, Stolzenbach LF et al Preoperative frailty predicts adverse short-term postoperative outcomes in patients treated with radical prostatectomy. Prostate Cancer Prostatic Dis. 2020;23:573–80. https://doi.org/10.1038/s41391-020-0225-3
  15. Lascano D, Pak JS, Kates M, Finkelstein JB, Silva M et al. Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools. Urol Oncol. 2015;33:426.e1-12. https://doi.org/10.1016/j.urolonc.2015.06.002
  16. Choi E, George A, Jakubski S, Almekdash MH, & Sharma P. Frailty is an independent predictor of 90-day complications following robot-assisted radical prostatectomy. SRCCC. 2022;10:15–21. https://doi.org/10.12746/swrccc.v10i44.1063
  17. Demirci A, Hamidi N, Uzel T, & Başar H. The 5-Factor Modified Frailty Index is effective in treatment decision and the determination of perioperative complications in patients with localized prostate cancer. Support Care Cancer. 2023;31:603. https://doi.org/10.1007/s00520-023-08078-7
  18. Shahait M, Labban M, Dobbs RW, Cheaib JG, Lee DI et al. A 5-item frailty index for predicting morbidity and mortality after radical prostatectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program Database. J Endourol. 2021;35:483–9. https://doi.org/10.1089/end.2020.0597
  19. Stankovic M, Weber C, Koser M, Weidner N. Frailty as Predictor for Early Functional Outcomes After Radical Prostatectomy. J Frailty Sarcopenia Falls. 2025;10:28–36. https://doi.org/10.22540/JFSF-10-028
  20. Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T et al. The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study). Urol Oncol. 2021;39:192.e7-192.e14. https://doi.org/10.1016/j.urolonc.2020.08.010
  21. Handforth C, Clegg A, Young C, Simpkins S, Seymour MT et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Annals Oncol 2015;26:1091–101. https://doi.org/10.1093/annonc/mdu540